Efficacy and tolerability of sunitinib in patients with advanced thyroid cancer out of a trial: A Spanish multicenter cohort.

E. Grande-Pulido,Beatriz Castelo,Paula J. Fonseca,Lara Iglesias,M. A. Vaz,Jorge Barriuso,M. Mangas Izquierdo,S. Guadalix,J.J. Diez,Juan Manuel Sepúlveda

Efficacy and tolerability of sunitinib in patients with advanced thyroid cancer out of a trial: A Spanish multicenter cohort.

2011

E. Grande-Pulido
Beatriz Castelo
Paula J. Fonseca
Lara Iglesias
M. A. Vaz
Jorge Barriuso
M. Mangas Izquierdo
S. Guadalix
J.J. Diez
Juan Manuel Sepúlveda

e16024 Background: Pathogenesis of thyroid carcinoma (TC) includes mutations and rearrangements of the tyrosine kinase (TK) domains of RET. In addition, microvascular density is increased and there...

Keywords:

Cohort
Thyroid cancer
Physical therapy
Medicine
Sunitinib
Tolerability
Tyrosine kinase
Pathogenesis
thyroid carcinoma
Microvascular Density

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations